Last ¥805.00 JPY
Change Today +12.00 / 1.51%
Volume 54.2K
4572 On Other Exchanges
As of 2:00 AM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

carna biosciences inc (4572) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/20/14 - ¥1,424
52 Week Low
05/21/14 - ¥410.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CARNA BIOSCIENCES INC (4572)

Related News

No related news articles were found.

carna biosciences inc (4572) Related Businessweek News

No Related Businessweek News Found

carna biosciences inc (4572) Details

Carna Biosciences, Inc. provides drug discovery supporting products and services; and discovers and develops drugs. Its drug discovery supporting products and services include kinase proteins; biotinylated kinases to use for the study of kinase-molecule interactions; profiling services; reverse phase protein array cell signaling analysis service to determine whether signaling pathways were affected inside a cell by a kinase inhibitor; live-cell kinase assays that offer tyrosine kinase profiling and screening services; ClariCELL kinase cell-based assay services; and co-crystallography services and crystal grade proteins. The company’s drug discovery supporting products and services also comprise assay development services, such as kinase genetic cloning, kinase protein production, substrate search optimization, and assay optimization services; and protein substrates to use for kinase assays. It also identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using its QuickScout, a kinase drug discovery platform. The company was founded in 2003 and is based in Kobe, Japan.

52 Employees
Last Reported Date: 03/26/14
Founded in 2003

carna biosciences inc (4572) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

carna biosciences inc (4572) Key Developments

Carna Biosciences, Inc. Announces Consolidated Earnings Results for the Second Quarter Ended June 30, 2014; Provides Earnings Guidance for the Full Year Ending December 31, 2014

Carna Biosciences, Inc. announced consolidated earnings results for the second quarter ended June 30, 2014. For the quarter, the company reported total revenue of JPY 306 million compared to JPY 341 million a year ago. Operating loss was JPY 277 million compared to JPY 169 million a year ago. Ordinary loss was JPY 257 million compared to JPY 147 million a year ago. Net loss was JPY 257 million or JPY 31.19 per share compared to JPY 151 million or JPY 20.66 per share a year ago. For the full year ending December 31, 2014, the company expects JPY 831 million and operating income of JPY 191 million.

Carna Biosciences, Inc., Q2 2014 Earnings Call, Aug 11, 2014

Carna Biosciences, Inc., Q2 2014 Earnings Call, Aug 11, 2014

Carna Biosciences, Inc. to Report Q2, 2014 Results on Aug 08, 2014

Carna Biosciences, Inc. announced that they will report Q2, 2014 results on Aug 08, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4572:JP ¥805.00 JPY +12.00

4572 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4572.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4572 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.5x
Price/Book 4.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARNA BIOSCIENCES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at